Format

Send to:

Choose Destination
See comment in PubMed Commons below
Clin Exp Rheumatol. 2000 Jul-Aug;18(4 Suppl 20):S58-60.

Steroid sparing therapeutic approaches to polymyalgia rheumatica-giant cell arteritis. State of the art and perspectives.

Author information

  • 1Division and Chair of Rheumatology, DPMSC, University of Udine, Italy. gianfranco.ferraccioli@dpmsc.uniud.it

Abstract

The therapeutic approach to polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) remains mainly based on corticosteroids. A few studies in PMR suggest a steroid-sparing effect with methotrexate in a subset of patients. No real alternative to steroids exists in GCA. Given the high chance of long-term treatment with corticosteroids in both diseases, randomized controlled trials with new immunosuppressive steroid-sparing drugs are eagerly awaited.

PMID:
10948766
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Write to the Help Desk